Are you ready? Have you made preparations and have alternate accounts available? What if they fine you some unknown amount for breaching their terms and conditions?
“Dutch outlet NRC conducted its own research on the money flows from anti-vaccine organizations, also regarding the Money Laundering and Terrorist Financing Prevention Act, according to the newspaper. The measure was taken to combat “extremism” and “dangerous” messaging. The financial service providers refusing these clients include the ING, Triodos Bank, Rabobank and payment platform Mollie.A Rabobank spokesperson confirmed to NRC that it no longer accepted customers who spread “conspiracy theories and other proven disinformation” because the bank considers their actions “harmful”.
“Anti-vaccine Dutch evangelist Jaap Dieleman saw his payment account with Mollie discontinued in February. Dieleman reaches millions of Dutch households. According to Mollie, Dieleman’s stance against getting vaccinated “do not fit with Mollie’s business operations”. Mollie also banned Café Weltschmerz, a popular YouTube channel that has called the Coronavirus narrative a conspiracy.
“Other service providers have refused to open accounts for prospective anti-vaccine clients. Triodos bank has refused to allow action group Viruswaarheid as a customer, since the group “called for confrontations that are at odds with our values”. NRC quoted from the refusal email the bank had sent to Viruswaarheid.”
In a recent study, we reported that certain anti-spike antibodies of COVID-19 and SARS-CoV viruses can have a pathogenic effect through binding to sick lung epithelium cells and misleading immune responses to attack self-cells. We termed this new pathogenic mechanism “Antibody Dependent Auto-Attack” (ADAA). This study explores a drug candidate for prevention and treatment of such ADAA-based diseases. The drug candidate is a formulation comprising N-acetylneuraminic acid methyl ester (NANA-Me), an analog of N-acetylneuraminic acid. NANA-Me acts through a unique mechanism of action (MOA) which is repairment of the missing sialic acid on sick lung epithelium cells. This MOA can block the antibodies’ binding to sick cells, which are vulnerable to pathogenic antibodies. Our in vivo data showed that the formulation significantly reduced the sickness and deaths caused by pathogenic anti-spike antibodies. Therefore, the formulation has the potential to prevent and treat the serious conditions caused by pathogenic antibodies during a COVID-19 infection. In addition, the formulation has potential to prevent and treat the adverse reactions of COVID-19 vaccines because the vaccines can induce similar antibodies, including pathogenic antibodies. The formulation will be helpful in increasing the safety of the vaccines without reducing the vaccine’s efficacy. Compared to existing antiviral drugs, the formulation has a unique MOA of targeting receptors, broad spectrum of indications, excellent safety profile, resistance to mutations, and can be easily produced.
The mandates will now become crushing. I wonder how many people who got their first two shots are really going to get their third. Ask some friends and leave a comment.
According to the New York Times and multiple media outlets, Pfizer is expected to get full FDA approval today. “The move would make it the first Covid vaccine to go from emergency use authorization to full FDA approval.” (read more) With that in mind, it is worth a reminder that both Pfizer and Moderna stopped the clinical trials the FDA was using in their review:
The Moderna and Pfizer vaccine tests were conducted, as customary, with a control group; a group within the trial who were given a placebo and not the test vaccine. However, during the trial -and after the untested vaccines were given emergency use authorization- the vaccine companies conducting the trial decided to break protocol and notify the control group they were not vaccinated. Almost all the control group were then given the vaccine.
Purposefully dissolving the placebo group violates the scientific purpose to test whether the vaccine has any efficacy; any actual benefit and/or safety issues. Without a control group there is nothing to compare the vaccinated group against. According to NPR, the doctors lost the control group in the Johnson County Clinicial Trial (Lexena, Kansas) on purpose:
(Via NPR) […] “Dr. Carlos Fierro, who runs the study there, says every participant was called back after the Food and Drug Administration authorized the vaccine.
“During that visit we discussed the options, which included staying in the study without the vaccine,” he says, “and amazingly there were people — a couple of people — who chose that.”
He suspects those individuals got spooked by rumors about the vaccine. But everybody else who had the placebo shot went ahead and got the actual vaccine. So now Fierro has essentially no comparison group left for the ongoing study. “It’s a loss from a scientific standpoint, but given the circumstances I think it’s the right thing to do,” he says.
People signing up for these studies were not promised special treatment, but once the FDA authorized the vaccines, their developers decided to offer the shots. (read more)
Just so we are clear, the final FDA authorization and approval for the vaccines are based on the outcome of these trials. As noted in the example above, the control group was intentionally lost under the auspices of “the right thing to do”, so there is no way for the efficacy, effectiveness or safety of the vaccine itself to be measured.
Well, PayPal has now claimed the right to not only cancel you, but also to charge you for it. Are you against vaccine mandates or mask mandates, have you violated any local ordinances or regulations, have you shared information that big brother would consider wrongthink? Get out now.
Amendments to the PayPal User Agreement
Effective: September 21, 2021
We are revising PayPal’s Seller Protection program to clarify eligibility for certain claims involving travel tickets sold by the travel carrier.
We are revising the length of time sellers have to notify us of any pricing errors or discrepancies to be sixty (60) days from having access to their account statement(s) or other account activity information.
We are clarifying the types of costs used to calculate the reasonable minimum estimate that we may recover if you engage in any restricted activities.
Amendments to the PayPal Acceptable Use Policy
Effective: September 21, 2021
We are revising the policy to clarify that violations may subject you to damages. We are also expanding the existing list of prohibited activities and clarifying the commercial activities requiring pre-approval.
Restricted Activities
In connection with your use of our websites, your PayPal account, the PayPal services, or in the course of your interactions with PayPal, other PayPal customers, or third parties, you must not:
Violate any law, statute, ordinance, or regulation;
Act in a manner that is defamatory, trade libelous, threatening or harassing;
Provide false, inaccurate or misleading information;
Send or receive what we reasonably believe to be potentially fraudulent funds;
Attempt to double dip during the course of a dispute by receiving or attempting to receive funds from both PayPal and the seller, bank or card issuer for the same transaction;
Control an account that is linked to another account that has engaged in any of these restricted activities;
Conduct your business or use the PayPal services in a manner that results in or may result in;
complaints;
requests by buyers (either filed with us or card issuers) to invalidate payments made to you;
fees, fines, penalties or other liability or losses to PayPal, other PayPal customers, third parties or you;
Use your PayPal account or the PayPal services in a manner that PayPal, Visa, MasterCard, American Express, Discover or any other electronic funds transfer network reasonably believes to be an abuse of the card system or a violation of card association or network rules;
Allow your PayPal account to have a negative balance;
Provide yourself a cash advance from your credit card (or help others to do so);
Take any action that imposes an unreasonable or disproportionately large load on our websites, software, systems (including any networks and servers used to provide any of the PayPal services) operated by us or on our behalf or the PayPal services;
Harass and/or threaten our employees, agents, or other users.
This means that Americans are surely being mowed down in the streets with AK fire, while our troops sit there with RoEs consisting of “use your inside voice.” It’s straight up disgusting, and if you’re not mad as hell, you should be. As each day passes, this operation appears more and more like intentional incompetence. Prove me wrong.
Wake up. Start getting ready for the panic with the vaxxed getting sicker and sicker as we descend into cold and flu season. Delta is real, and whatever it is, it seems to be much worse than the old rona, and we have already seen a study where ADE is happening. Are you making popcorn to watch the war of the thrice jabbed against the merely twice jabbed? That should be good viewing. Strong rumors circulating that one of the brands will received full FDA approval next week. Meanwhile, vaxx mandates are mushrooming and pushback seems to be growing. It’s pretty tough to run a hospital when all your nurses are quitting and the bedpan scrubbers are going to work at McDonald’s for $23/hr. But you can be assured that more mandates are coming, and you better be wargaming your own offensive. To put you in the right mindest, here is a warm look back to just this past May, where I tried to explain the background of the Moderna monstrosity, which is how this story line got started.
Former Moderna scientist: “It’s a case of the emperor’s new clothes. They’re running an investment firm, and then hopefully it also develops a drug that’s successful.”
Posted on
I’m just going to go ahead and paste here from wiki about the ten year history of failure, failure, and nothing but failure from Moderna. It looks more like a money-laundering outfit than anything else. So ask yourself, how is it that after ten years of producing nothing, they were able to come up with a highly safe and highly effective Corona vaxx to enter into human trials just five WEEKS.
At the very end, you will read about the promise they made to Trump, and you will understand a great many things:
In 2011, the CEO of Flagship Ventures (now Flagship Pioneering), Noubar Afeyan, brought in European pharma sales and operations executive Stéphane Bancel as CEO.[23][11] Afeyan personally owned 19.5% of Moderna and was the largest single shareholder, while his fund, Flagship Pioneering, owned 18%.[26]
In March 2013, Moderna and AstraZeneca signed a five-year exclusive option agreement to discover, develop, and commercialize mRNA for treatments in the therapeutic areas of cardiovascular, metabolic, and renal diseases, and selected targets for cancer.[11][27][28] The agreement included a $240 million upfront payment to Moderna, a payment which was “one of the largest ever initial payments in a pharmaceutical industry licensing deal that does not involve a drug already being tested in clinical trials”,[27] and an eight percent share in Moderna.[26] As of May 2020, only one candidate has passed Phase I trials, a treatment for myocardial ischemia, labelled AZD8601.[a][30]
In 2013, Rossi, Chien and their team reported that they were able to improve heart function in mice and enhance their long-term survival with a “redirection of their [stem cell] differentiation toward cardiovascular cell types” in a significant step towards regenerative therapeutics for Moderna.[31][32] In the same year and on the strength of the Nature Biotechnology paper, Moderna received from other investors $110 million.[31]
In January 2014, Moderna and Alexion Pharmaceuticals entered a $125 million deal for orphan diseases in need of therapies. Alexion paid Moderna $100 million for ten product options to develop rare-disease treatments, including for Crigler-Najjar syndrome, using Moderna’s mRNA therapeutics platform.[33]By 2016, Bancel told an audience of JPMorgan Chase investors that the work with Alexion would shortly enter human trials. However, by 2017, the program with Alexion had been scrapped as the animal trials showed that Moderna’s treatment would never be safe enough for humans.[11][12]
In February 2016, a Nature editorial criticized Moderna for not publishing any peer-reviewed papers on its technology, unlike most other emerging and established biotech companies, and compared its approach to that of the controversially failed Theranos.[34] In September 2018, Thrillist published an article titled, “Why This Secretive Tech Start-Up Could Be The Next Theranos”,[35] criticizing its reputation for secrecy and the absence of scientific validation or independent peer-review of its research, though having the highest valuation of any U.S. private biotech company at more than $5 billion.[11][36]A former Moderna scientist told Stat: “It’s a case of the emperor’s new clothes. They’re running an investment firm, and then hopefully it also develops a drug that’s successful.”[11]
In 2018, the company rebranded as “Moderna Inc.” with the ticker symbol MRNA, and further increased its portfolio of vaccine development.[10] In December 2018, Moderna became the largest biotech initial public offering in history, raising $621 million (27 million shares at $23 per share) on NASDAQ, and implying an overall valuation of $7.5 billion for the entire company.[37][38]The year-end 2019 SEC filings showed that Moderna had accumulated losses of $1.5 billion since inception, with a loss of $514 million in 2019 alone, and had raised $3.2 billion in equity since 2010.[10][26]
In March 2020, in a White House meeting between the Trump administration and pharmaceutical executives, Bancel told the president Moderna could have a COVID-19 vaccine ready in a few months.[10] The next day, the FDA approved clinical trials for the Moderna vaccine candidate, with Moderna later receiving investment of $483 million from Operation Warp Speed.[10] Moderna board member, Moncef Slaoui, was appointed head scientist for the Operation Warp Speed project.[10]
